Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Department of Family Medicine, Maccabi Healthcare Services, Tel Aviv University, Hamered 27 St., Tel Aviv, Israel.
BMC Prim Care. 2024 Mar 19;25(1):92. doi: 10.1186/s12875-024-02324-5.
The prevalence of obesity has been increasing worldwide and is associated with increased risk of morbidity and mortality. Weight management can reduce the risk of complications and improve the quality of life of patients with obesity. This study explored primary care physicians' (PCPs') attitudes and knowledge about weight management.
An anonymous questionnaire was distributed to 400 PCPs between 2020 and 2021. The survey included questions on treatment approaches (pharmaceutical and surgical) and items regarding the respondents' demographic characteristics. We compared PCPs with low or high proactivity toward weight management. We explored attitudes and knowledge with the chi-square test for categorical variables or the Mann-Whitney test for continuous variables.
A total of 145 PCPs answered our survey (a response rate of 36.25%). More than half (53.8%) of the respondents showed low proactivity toward weight management in their practice. Proactive respondents were more likely to believe that pharmaceutical treatment effectively reduces weight and offered medical and surgical treatment options more frequently to their patients. Lack of knowledge was the most predominant reason for PCPs avoiding offering treatment to their patients, especially in less proactive PCPs (33.3% vs. 5.3%, p-value < 0.001). When comparing different pharmaceutical options, 46.6% of PCPs report they tend to prescribe liraglutide to their patients compared with only 11% who prescribe orlistat and 10.3% who prescribe phentermine (p-value < 0.001).
Many PCPs still do not actively provide obesity treatment despite improved awareness and therapeutic options. PCPs' proactivity and attitudes are vital to this effort.
肥胖的患病率在全球范围内不断上升,与发病率和死亡率的增加相关。体重管理可以降低并发症的风险,提高肥胖患者的生活质量。本研究探讨了初级保健医生(PCP)对体重管理的态度和知识。
在 2020 年至 2021 年期间,我们向 400 名 PCP 分发了匿名问卷。该调查包括关于治疗方法(药物和手术)的问题以及关于受访者人口统计学特征的项目。我们比较了对体重管理积极性低或高的 PCP。我们使用卡方检验比较分类变量,或使用曼-惠特尼检验比较连续变量来探讨态度和知识。
共有 145 名 PCP 回答了我们的调查(回应率为 36.25%)。超过一半(53.8%)的受访者在实践中对体重管理的积极性较低。积极的受访者更倾向于认为药物治疗能有效减轻体重,并更频繁地向患者提供医疗和手术治疗选择。缺乏知识是 PCP 避免为患者提供治疗的最主要原因,尤其是在积极性较低的 PCP 中(33.3%比 5.3%,p 值<0.001)。在比较不同的药物选择时,46.6%的 PCP 报告说他们倾向于为患者开利拉鲁肽,而只有 11%的 PCP 开奥利司他,10.3%的 PCP 开苯丁胺(p 值<0.001)。
尽管治疗意识和治疗选择有所提高,但许多 PCP 仍未积极提供肥胖治疗。PCP 的积极性和态度对这一努力至关重要。